Takeda Pharmaceutical Company Limited
USD15.19
-0.77 (-4.82%)
CEO
Christophe Weber
IPO Date
2010-01-05
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
Country
JP
Open
$15.33
Prev. Close
$15.96
Day Low
$15.08
Day High
$15.50
52W Low
$12.99
52W High
$18.90
Market Cap
$48.00B
Volume
4.11M
| 78,900 |
| $0.00 |
| 28 Apr 2026 | Weber Christophe Pierre | director, officer: President and CEO | A-Award | Acquired | 165,370 | $0.00 |
| 28 Apr 2026 | Weber Christophe Pierre | director, officer: President and CEO | A-Award | Acquired | 78,978 | $0.00 |
| 28 Apr 2026 | Furuta Milano | director, officer: Chief Financial Officer | A-Award | Acquired | 7,800 | $0.00 |
| 28 Apr 2026 | Furuta Milano | director, officer: Chief Financial Officer | A-Award | Acquired | 7,814 | $0.00 |
| 28 Apr 2026 | Plump Andrew Stewart | director, officer: President, R&D | A-Award | Acquired | 212,470 | $0.00 |
| 28 Apr 2026 | Ricci Gabriele | Chief Data & Tech. Officer | A-Award | Acquired | 34,994 | $0.00 |
| 28 Apr 2026 | Bitetti Teresa Marie | President, OBU | A-Award | Acquired | 64,988 | $0.00 |
| 28 Apr 2026 | Duprey Lauren Rusckowski | Chief Transformation Officer | A-Award | Acquired | 59,990 | $0.00 |
| 20 Mar 2023 | Daniel Goldman | Daniel Goldman | Purchase | $1,001 - $15,000 |
| 8 Mar 2023 | Ro Khanna | Ro Khanna | Purchase | $15,001 - $50,000 |
| 3 Mar 2023 | Virginia Foxx | Virginia Foxx | Purchase | $1,001 - $15,000 |
| 6 Dec 2022 | Virginia Foxx | Virginia Foxx | Purchase | $1,001 - $15,000 |